Zorana Vasiljevic
Overview
Explore the profile of Zorana Vasiljevic including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
78
Citations
839
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vasiljevic Z, Zlatic N, Rajic D, Mitrovic P, Viduljevic M, Matic D, et al.
Curr Pharm Des
. 2024 Oct;
31(6):484-492.
PMID: 39364862
Introduction: The current study aims to investigate the blood Hcy levels in patients with CAD and hypertension in Serbia, a country with a high incidence and mortality of both diseases....
2.
Fabin N, Cenko E, Bergami M, Yoon J, Vadala G, Mendieta G, et al.
Cardiovasc Res
. 2024 Aug;
120(16):2064-2077.
PMID: 39196713
Aims: To investigate the impact of an early coronary revascularization (<24 h) compared with initial conservative strategy on clinical outcomes in diabetic patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS)...
3.
Cenko E, Manfrini O, Yoon J, van der Schaar M, Bergami M, Vasiljevic Z, et al.
JACC Adv
. 2024 Jun;
2(3):100294.
PMID: 38939586
Background: There have been conflicting reports regarding outcomes in women presenting with an acute coronary syndrome (ACS). Objectives: The objective of the study was to examine sex-specific differences in 30-day...
4.
Cenko E, Yoon J, Bergami M, Gale C, Vasiljevic Z, Vavlukis M, et al.
Eur Heart J Qual Care Clin Outcomes
. 2024 May;
PMID: 38714331
Background: Existing data on female sex and excess cardiovascular mortality after myocardial infarction (MI) mostly come from high-income countries (HICs). This study aimed to investigate how sex disparities in treatments...
5.
Bugiardini R, Cenko E, Yoon J, Bergami M, Vasiljevic Z, Mendieta G, et al.
Lancet Reg Health Eur
. 2024 Mar;
38:100824.
PMID: 38476741
Background: The age-standardized death rates under 65 years from ischemic heart disease in South Eastern Europe are approximately twice as high than the Western Europe average, but the reasons are...
6.
Zdravkovic M, Popadic V, Klasnja S, Klasnja A, Ivankovic T, Lasica R, et al.
Medicina (Kaunas)
. 2023 Dec;
59(12).
PMID: 38138252
Coronary microvascular dysfunction (CMD) is a clinical entity linked with various risk factors that significantly affect cardiac morbidity and mortality. Hypertension, one of the most important, causes both functional and...
7.
Cenko E, Manfrini O, Fabin N, Dorobantu M, Kedev S, Milicic D, et al.
Lancet Reg Health Eur
. 2023 Nov;
33:100698.
PMID: 37954000
Cardiovascular inequalities remain pervasive in the European countries. Disparities in disease burden is apparent among population groups based on sex, ethnicity, economic status or geography. To address this challenge, The...
8.
Bergami M, Manfrini O, Nava S, Caramori G, Yoon J, Badimon L, et al.
J Am Heart Assoc
. 2023 Jul;
12(14):e028939.
PMID: 37449568
Background Empiric antimicrobial therapy with azithromycin is highly used in patients admitted to the hospital with COVID-19, despite prior research suggesting that azithromycin may be associated with increased risk of...
9.
Bugiardini R, Nava S, Caramori G, Yoon J, Badimon L, Bergami M, et al.
Cardiovasc Res
. 2023 Jan;
119(5):1190-1201.
PMID: 36651866
Aims: Previous analyses on sex differences in case fatality rates at population-level data had limited adjustment for key patient clinical characteristics thought to be associated with coronavirus disease 2019 (COVID-19)...
10.
Vasic A, Vasiljevic Z, Mickovski-Katalina N, Mandic-Rajcevic S, Soldatovic I
Int J Environ Res Public Health
. 2022 Nov;
19(21).
PMID: 36361340
Background: Cardiovascular diseases ranked first in terms of the number of deaths in Serbia in 2019, with 52,663 deaths. One fifth of those were from ischemic heart disease (IHD), and...